The FDA placed a partial hold on a phase 2 lorigerlimab trial in gynecologic cancers after a patient died from grade 4 ...

A patient has died in a mid-stage study of MacroGenics’ bispecific antibody lorigerlimab in gynecologic cancers, prompting ...

The FDA has placed a partial clinical hold on a cancer drug trial following four safety events, including one death, according to a Feb. 25 announcement from MacroGenics.  The partial hold pauses ...

CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Encouraging Results from Phase 2 HIT Trial On February 24, 2026, Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) announced encouraging results from ...

SOUTH SAN FRANCISCO, CA / ACCESS Newswire / February 25, 2026 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing CID-103, a potential ...

Doctors at Yashoda Hospitals, Somajiguda, successfully treated a 10-month-old baby diagnosed with a rare bone marrow disorder, CAMT. A life-saving stem cell transplant using the father as a half-match ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Wednesday, February 25, 2026. Let’s ...

A groundbreaking study explains why certain COVID-19 vaccines caused dangerous blood clots, hemorrhages and VITT syndrome, ...

A 17-year-old student died from a rare condition after being struck down with food poisoning which may have been caused by ...

Data from the pivotal ENERGY trial showed IMAAVY® produced a rapid and durable hemoglobin responsea in wAIHA Currently no FDA-approved therapies are available for wAIHA ...

Interparfums (NASDAQ:IPAR) executives highlighted record 2025 results and detailed how tariffs, foreign exchange, and ...

Carrie Dannar, a licensed practical nurse working in wound care at Mosaic Medical Center – Maryville, was honored with The ...